205 related articles for article (PubMed ID: 25866142)
41. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
42. Lactate acid promotes PD-1
Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B
Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414
[TBL] [Abstract][Full Text] [Related]
43. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
Bruserud O
Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
[TBL] [Abstract][Full Text] [Related]
44. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
Zhong RK; Lane TA; Ball ED
Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
[TBL] [Abstract][Full Text] [Related]
45. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
46. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
47. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
48. Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.
Rambaldi A; Torcia M; Dinarello CA; Barbui T; Cozzolino F
Leukemia; 1993 Aug; 7 Suppl 2():S10-2. PubMed ID: 8361209
[TBL] [Abstract][Full Text] [Related]
49. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
50. HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia.
Locafaro G; Amodio G; Tomasoni D; Tresoldi C; Ciceri F; Gregori S
J Immunol Res; 2014; 2014():636292. PubMed ID: 24741612
[TBL] [Abstract][Full Text] [Related]
51. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
[TBL] [Abstract][Full Text] [Related]
52. IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.
Nakase K; Kita K; Katayama N
Med Hypotheses; 2018 Jun; 115():5-7. PubMed ID: 29685196
[TBL] [Abstract][Full Text] [Related]
53. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia.
Bruserud O; Ulvestad E
J Interferon Cytokine Res; 2000 Nov; 20(11):947-54. PubMed ID: 11096451
[TBL] [Abstract][Full Text] [Related]
54. Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1 beta in the autonomous growth of acute myeloblastic leukaemia cells--studies using purified CD34-positive cells.
Bradbury D; Rogers S; Reilly IA; Kozlowski R; Russell NH
Leukemia; 1992 Jun; 6(6):562-6. PubMed ID: 1376378
[TBL] [Abstract][Full Text] [Related]
55. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
56. IL-4, IL-10 and IL-13 in acute myelogenous leukemia.
Bruserud O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844
[TBL] [Abstract][Full Text] [Related]
57. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
58. [Expression of Tregs and IL-35 in Peripheral Blood of Patients with Newly Diagnosed Acute Myeloid Leukemia].
Yang PX; Wang P; Fang L; Wang Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1688-1692. PubMed ID: 36476890
[TBL] [Abstract][Full Text] [Related]
59. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.
Mussai F; De Santo C; Abu-Dayyeh I; Booth S; Quek L; McEwen-Smith RM; Qureshi A; Dazzi F; Vyas P; Cerundolo V
Blood; 2013 Aug; 122(5):749-58. PubMed ID: 23733335
[TBL] [Abstract][Full Text] [Related]
60. After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia.
Delia M; Carluccio P; Mestice A; Frappampina R; Albano F; Specchia G; Musto P
J Immunol Res; 2020; 2020():2134647. PubMed ID: 33204734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
